aluates Reports

$ 0.0

Automative

Global Electrocompetent Cells Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-25Z6076

Global Electrocompetent Cells Market Insights and Forecast to 2028

BUY CHAPTERS

Global Electrocompetent Cells Market Research Report 2025

Code: QYRE-Auto-25Z6076

Report

September 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N V

Origene Technologies

Lucigen

Zymo Research

Bio Rad Laboratories

Bioline

Delphi Genetics

IBA

Cell Applications

BioDynamics Laboratory

Scarab Genomics

Electrocompetent Cells Market Size

The global market for Electrocompetent Cells was valued at US$ 841 million in the year 2024 and is projected to reach a revised size of US$ 1573 million by 2031, growing at a CAGR of 9.5% during the forecast period.

Electrocompetent Cells Market

Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.

North American market for Electrocompetent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Electrocompetent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Electrocompetent Cells in Subcloning & Routine Cloning is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Electrocompetent Cells include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Electrocompetent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Electrocompetent Cells.

The Electrocompetent Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Electrocompetent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Electrocompetent Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Electrocompetent Cells Market Report

Report Metric	Details
Report Name	Electrocompetent Cells Market
Accounted market size in year	US$ 841 million
Forecasted market size in 2031	US$ 1573 million
CAGR	9.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cloned Competent Cells Agrobacterium tumefaciens Competent Cells Expression Competent Cells
Segment by Application	Subcloning & Routine Cloning Phage Display Library Construction Toxic/Unstable Dna Cloning High-Throughput Cloning Protein Expression Mutagenesis Single-Stranded Dna Production Bacmid creation Cre-lox recombination (PIR1/PIR2)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Electrocompetent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Electrocompetent Cells Market growing?

Ans: The Electrocompetent Cells Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the Electrocompetent Cells Market size in 2031?

Ans: The Electrocompetent Cells Market size in 2031 will be US$ 1573 million.

Who are the main players in the Electrocompetent Cells Market report?

Ans: The main players in the Electrocompetent Cells Market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics

What are the Application segmentation covered in the Electrocompetent Cells Market report?

Ans: The Applications covered in the Electrocompetent Cells Market report are Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)

What are the Type segmentation covered in the Electrocompetent Cells Market report?

Ans: The Types covered in the Electrocompetent Cells Market report are Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Electrocompetent Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cloned Competent Cells

1.2.3 Agrobacterium tumefaciens Competent Cells

1.2.4 Expression Competent Cells

1.3 Market by Application

1.3.1 Global Electrocompetent Cells Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Subcloning & Routine Cloning

1.3.3 Phage Display Library Construction

1.3.4 Toxic/Unstable Dna Cloning

1.3.5 High-Throughput Cloning

1.3.6 Protein Expression

1.3.7 Mutagenesis

1.3.8 Single-Stranded Dna Production

1.3.9 Bacmid creation

1.3.10 Cre-lox recombination (PIR1/PIR2)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Electrocompetent Cells Market Perspective (2020-2031)

2.2 Global Electrocompetent Cells Growth Trends by Region

2.2.1 Global Electrocompetent Cells Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Electrocompetent Cells Historic Market Size by Region (2020-2025)

2.2.3 Electrocompetent Cells Forecasted Market Size by Region (2026-2031)

2.3 Electrocompetent Cells Market Dynamics

2.3.1 Electrocompetent Cells Industry Trends

2.3.2 Electrocompetent Cells Market Drivers

2.3.3 Electrocompetent Cells Market Challenges

2.3.4 Electrocompetent Cells Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Electrocompetent Cells Players by Revenue

3.1.1 Global Top Electrocompetent Cells Players by Revenue (2020-2025)

3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2020-2025)

3.2 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Electrocompetent Cells Revenue

3.4 Global Electrocompetent Cells Market Concentration Ratio

3.4.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2024

3.5 Global Key Players of Electrocompetent Cells Head office and Area Served

3.6 Global Key Players of Electrocompetent Cells, Product and Application

3.7 Global Key Players of Electrocompetent Cells, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Electrocompetent Cells Breakdown Data by Type

4.1 Global Electrocompetent Cells Historic Market Size by Type (2020-2025)

4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2026-2031)

5 Electrocompetent Cells Breakdown Data by Application

5.1 Global Electrocompetent Cells Historic Market Size by Application (2020-2025)

5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Electrocompetent Cells Market Size (2020-2031)

6.2 North America Electrocompetent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Electrocompetent Cells Market Size by Country (2020-2025)

6.4 North America Electrocompetent Cells Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Electrocompetent Cells Market Size (2020-2031)

7.2 Europe Electrocompetent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Electrocompetent Cells Market Size by Country (2020-2025)

7.4 Europe Electrocompetent Cells Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Electrocompetent Cells Market Size (2020-2031)

8.2 Asia-Pacific Electrocompetent Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Electrocompetent Cells Market Size by Region (2020-2025)

8.4 Asia-Pacific Electrocompetent Cells Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Electrocompetent Cells Market Size (2020-2031)

9.2 Latin America Electrocompetent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Electrocompetent Cells Market Size by Country (2020-2025)

9.4 Latin America Electrocompetent Cells Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Electrocompetent Cells Market Size (2020-2031)

10.2 Middle East & Africa Electrocompetent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Electrocompetent Cells Market Size by Country (2020-2025)

10.4 Middle East & Africa Electrocompetent Cells Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck KGaA

11.1.1 Merck KGaA Company Details

11.1.2 Merck KGaA Business Overview

11.1.3 Merck KGaA Electrocompetent Cells Introduction

11.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2020-2025)

11.1.5 Merck KGaA Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction

11.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Details

11.3.2 Agilent Technologies Business Overview

11.3.3 Agilent Technologies Electrocompetent Cells Introduction

11.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2020-2025)

11.3.5 Agilent Technologies Recent Development

11.4 Takara Bio

11.4.1 Takara Bio Company Details

11.4.2 Takara Bio Business Overview

11.4.3 Takara Bio Electrocompetent Cells Introduction

11.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2020-2025)

11.4.5 Takara Bio Recent Development

11.5 Promega Corporation

11.5.1 Promega Corporation Company Details

11.5.2 Promega Corporation Business Overview

11.5.3 Promega Corporation Electrocompetent Cells Introduction

11.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2020-2025)

11.5.5 Promega Corporation Recent Development

11.6 Beijing TransGen Biotech

11.6.1 Beijing TransGen Biotech Company Details

11.6.2 Beijing TransGen Biotech Business Overview

11.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction

11.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2020-2025)

11.6.5 Beijing TransGen Biotech Recent Development

11.7 GeneScript Corporation

11.7.1 GeneScript Corporation Company Details

11.7.2 GeneScript Corporation Business Overview

11.7.3 GeneScript Corporation Electrocompetent Cells Introduction

11.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2020-2025)

11.7.5 GeneScript Corporation Recent Development

11.8 Yeastern Biotech

11.8.1 Yeastern Biotech Company Details

11.8.2 Yeastern Biotech Business Overview

11.8.3 Yeastern Biotech Electrocompetent Cells Introduction

11.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2020-2025)

11.8.5 Yeastern Biotech Recent Development

11.9 New England Biolabs

11.9.1 New England Biolabs Company Details

11.9.2 New England Biolabs Business Overview

11.9.3 New England Biolabs Electrocompetent Cells Introduction

11.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2020-2025)

11.9.5 New England Biolabs Recent Development

11.10 QIAGEN N.V.

11.10.1 QIAGEN N.V. Company Details

11.10.2 QIAGEN N.V. Business Overview

11.10.3 QIAGEN N.V. Electrocompetent Cells Introduction

11.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2020-2025)

11.10.5 QIAGEN N.V. Recent Development

11.11 OriGene Technologies

11.11.1 OriGene Technologies Company Details

11.11.2 OriGene Technologies Business Overview

11.11.3 OriGene Technologies Electrocompetent Cells Introduction

11.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2020-2025)

11.11.5 OriGene Technologies Recent Development

11.12 Lucigen

11.12.1 Lucigen Company Details

11.12.2 Lucigen Business Overview

11.12.3 Lucigen Electrocompetent Cells Introduction

11.12.4 Lucigen Revenue in Electrocompetent Cells Business (2020-2025)

11.12.5 Lucigen Recent Development

11.13 Zymo Research

11.13.1 Zymo Research Company Details

11.13.2 Zymo Research Business Overview

11.13.3 Zymo Research Electrocompetent Cells Introduction

11.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2020-2025)

11.13.5 Zymo Research Recent Development

11.14 Bio-Rad Laboratories

11.14.1 Bio-Rad Laboratories Company Details

11.14.2 Bio-Rad Laboratories Business Overview

11.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction

11.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2020-2025)

11.14.5 Bio-Rad Laboratories Recent Development

11.15 Bioline

11.15.1 Bioline Company Details

11.15.2 Bioline Business Overview

11.15.3 Bioline Electrocompetent Cells Introduction

11.15.4 Bioline Revenue in Electrocompetent Cells Business (2020-2025)

11.15.5 Bioline Recent Development

11.16 Delphi Genetics

11.16.1 Delphi Genetics Company Details

11.16.2 Delphi Genetics Business Overview

11.16.3 Delphi Genetics Electrocompetent Cells Introduction

11.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2020-2025)

11.16.5 Delphi Genetics Recent Development

11.17 IBA GmBH

11.17.1 IBA GmBH Company Details

11.17.2 IBA GmBH Business Overview

11.17.3 IBA GmBH Electrocompetent Cells Introduction

11.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2020-2025)

11.17.5 IBA GmBH Recent Development

11.18 Cell Applications

11.18.1 Cell Applications Company Details

11.18.2 Cell Applications Business Overview

11.18.3 Cell Applications Electrocompetent Cells Introduction

11.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2020-2025)

11.18.5 Cell Applications Recent Development

11.19 BioDynamics Laboratory

11.19.1 BioDynamics Laboratory Company Details

11.19.2 BioDynamics Laboratory Business Overview

11.19.3 BioDynamics Laboratory Electrocompetent Cells Introduction

11.19.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2020-2025)

11.19.5 BioDynamics Laboratory Recent Development

11.20 Scarab Genomics

11.20.1 Scarab Genomics Company Details

11.20.2 Scarab Genomics Business Overview

11.20.3 Scarab Genomics Electrocompetent Cells Introduction

11.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2020-2025)

11.20.5 Scarab Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N V

Origene Technologies

Lucigen

Zymo Research

Bio Rad Laboratories

Bioline

Delphi Genetics

IBA

Cell Applications

BioDynamics Laboratory

Scarab Genomics

List of Tables

Table 1. Global Electrocompetent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cloned Competent Cells

Table 3. Key Players of Agrobacterium tumefaciens Competent Cells

Table 4. Key Players of Expression Competent Cells

Table 5. Global Electrocompetent Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Electrocompetent Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Electrocompetent Cells Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Electrocompetent Cells Market Share by Region (2020-2025)

Table 9. Global Electrocompetent Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Electrocompetent Cells Market Share by Region (2026-2031)

Table 11. Electrocompetent Cells Market Trends

Table 12. Electrocompetent Cells Market Drivers

Table 13. Electrocompetent Cells Market Challenges

Table 14. Electrocompetent Cells Market Restraints

Table 15. Global Electrocompetent Cells Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Electrocompetent Cells Market Share by Players (2020-2025)

Table 17. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2024)

Table 18. Ranking of Global Top Electrocompetent Cells Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Electrocompetent Cells Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Electrocompetent Cells, Headquarters and Area Served

Table 21. Global Key Players of Electrocompetent Cells, Product and Application

Table 22. Global Key Players of Electrocompetent Cells, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Electrocompetent Cells Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Electrocompetent Cells Revenue Market Share by Type (2020-2025)

Table 26. Global Electrocompetent Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Electrocompetent Cells Revenue Market Share by Type (2026-2031)

Table 28. Global Electrocompetent Cells Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Electrocompetent Cells Revenue Market Share by Application (2020-2025)

Table 30. Global Electrocompetent Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Electrocompetent Cells Revenue Market Share by Application (2026-2031)

Table 32. North America Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Electrocompetent Cells Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Electrocompetent Cells Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Electrocompetent Cells Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Electrocompetent Cells Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Electrocompetent Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Electrocompetent Cells Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Electrocompetent Cells Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Electrocompetent Cells Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Electrocompetent Cells Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Electrocompetent Cells Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Electrocompetent Cells Market Size by Country (2026-2031) & (US$ Million)

Table 47. Merck KGaA Company Details

Table 48. Merck KGaA Business Overview

Table 49. Merck KGaA Electrocompetent Cells Product

Table 50. Merck KGaA Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 51. Merck KGaA Recent Development

Table 52. Thermo Fisher Scientific Company Details

Table 53. Thermo Fisher Scientific Business Overview

Table 54. Thermo Fisher Scientific Electrocompetent Cells Product

Table 55. Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific Recent Development

Table 57. Agilent Technologies Company Details

Table 58. Agilent Technologies Business Overview

Table 59. Agilent Technologies Electrocompetent Cells Product

Table 60. Agilent Technologies Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 61. Agilent Technologies Recent Development

Table 62. Takara Bio Company Details

Table 63. Takara Bio Business Overview

Table 64. Takara Bio Electrocompetent Cells Product

Table 65. Takara Bio Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 66. Takara Bio Recent Development

Table 67. Promega Corporation Company Details

Table 68. Promega Corporation Business Overview

Table 69. Promega Corporation Electrocompetent Cells Product

Table 70. Promega Corporation Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 71. Promega Corporation Recent Development

Table 72. Beijing TransGen Biotech Company Details

Table 73. Beijing TransGen Biotech Business Overview

Table 74. Beijing TransGen Biotech Electrocompetent Cells Product

Table 75. Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 76. Beijing TransGen Biotech Recent Development

Table 77. GeneScript Corporation Company Details

Table 78. GeneScript Corporation Business Overview

Table 79. GeneScript Corporation Electrocompetent Cells Product

Table 80. GeneScript Corporation Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 81. GeneScript Corporation Recent Development

Table 82. Yeastern Biotech Company Details

Table 83. Yeastern Biotech Business Overview

Table 84. Yeastern Biotech Electrocompetent Cells Product

Table 85. Yeastern Biotech Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 86. Yeastern Biotech Recent Development

Table 87. New England Biolabs Company Details

Table 88. New England Biolabs Business Overview

Table 89. New England Biolabs Electrocompetent Cells Product

Table 90. New England Biolabs Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 91. New England Biolabs Recent Development

Table 92. QIAGEN N.V. Company Details

Table 93. QIAGEN N.V. Business Overview

Table 94. QIAGEN N.V. Electrocompetent Cells Product

Table 95. QIAGEN N.V. Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 96. QIAGEN N.V. Recent Development

Table 97. OriGene Technologies Company Details

Table 98. OriGene Technologies Business Overview

Table 99. OriGene Technologies Electrocompetent Cells Product

Table 100. OriGene Technologies Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 101. OriGene Technologies Recent Development

Table 102. Lucigen Company Details

Table 103. Lucigen Business Overview

Table 104. Lucigen Electrocompetent Cells Product

Table 105. Lucigen Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 106. Lucigen Recent Development

Table 107. Zymo Research Company Details

Table 108. Zymo Research Business Overview

Table 109. Zymo Research Electrocompetent Cells Product

Table 110. Zymo Research Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 111. Zymo Research Recent Development

Table 112. Bio-Rad Laboratories Company Details

Table 113. Bio-Rad Laboratories Business Overview

Table 114. Bio-Rad Laboratories Electrocompetent Cells Product

Table 115. Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 116. Bio-Rad Laboratories Recent Development

Table 117. Bioline Company Details

Table 118. Bioline Business Overview

Table 119. Bioline Electrocompetent Cells Product

Table 120. Bioline Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 121. Bioline Recent Development

Table 122. Delphi Genetics Company Details

Table 123. Delphi Genetics Business Overview

Table 124. Delphi Genetics Electrocompetent Cells Product

Table 125. Delphi Genetics Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 126. Delphi Genetics Recent Development

Table 127. IBA GmBH Company Details

Table 128. IBA GmBH Business Overview

Table 129. IBA GmBH Electrocompetent Cells Product

Table 130. IBA GmBH Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 131. IBA GmBH Recent Development

Table 132. Cell Applications Company Details

Table 133. Cell Applications Business Overview

Table 134. Cell Applications Electrocompetent Cells Product

Table 135. Cell Applications Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 136. Cell Applications Recent Development

Table 137. BioDynamics Laboratory Company Details

Table 138. BioDynamics Laboratory Business Overview

Table 139. BioDynamics Laboratory Electrocompetent Cells Product

Table 140. BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 141. BioDynamics Laboratory Recent Development

Table 142. Scarab Genomics Company Details

Table 143. Scarab Genomics Business Overview

Table 144. Scarab Genomics Electrocompetent Cells Product

Table 145. Scarab Genomics Revenue in Electrocompetent Cells Business (2020-2025) & (US$ Million)

Table 146. Scarab Genomics Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Electrocompetent Cells Picture

Figure 2. Global Electrocompetent Cells Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Electrocompetent Cells Market Share by Type: 2024 VS 2031

Figure 4. Cloned Competent Cells Features

Figure 5. Agrobacterium tumefaciens Competent Cells Features

Figure 6. Expression Competent Cells Features

Figure 7. Global Electrocompetent Cells Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Electrocompetent Cells Market Share by Application: 2024 VS 2031

Figure 9. Subcloning & Routine Cloning Case Studies

Figure 10. Phage Display Library Construction Case Studies

Figure 11. Toxic/Unstable Dna Cloning Case Studies

Figure 12. High-Throughput Cloning Case Studies

Figure 13. Protein Expression Case Studies

Figure 14. Mutagenesis Case Studies

Figure 15. Single-Stranded Dna Production Case Studies

Figure 16. Bacmid creation Case Studies

Figure 17. Cre-lox recombination (PIR1/PIR2) Case Studies

Figure 18. Electrocompetent Cells Report Years Considered

Figure 19. Global Electrocompetent Cells Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 20. Global Electrocompetent Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Electrocompetent Cells Market Share by Region: 2024 VS 2031

Figure 22. Global Electrocompetent Cells Market Share by Players in 2024

Figure 23. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2024)

Figure 24. The Top 10 and 5 Players Market Share by Electrocompetent Cells Revenue in 2024

Figure 25. North America Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. North America Electrocompetent Cells Market Share by Country (2020-2031)

Figure 27. United States Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Canada Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Electrocompetent Cells Market Share by Country (2020-2031)

Figure 31. Germany Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. France Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. U.K. Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Italy Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Russia Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Nordic Countries Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Electrocompetent Cells Market Share by Region (2020-2031)

Figure 39. China Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Japan Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. India Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Australia Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Electrocompetent Cells Market Share by Country (2020-2031)

Figure 47. Mexico Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Brazil Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Electrocompetent Cells Market Share by Country (2020-2031)

Figure 51. Turkey Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. UAE Electrocompetent Cells Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Merck KGaA Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 56. Agilent Technologies Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 57. Takara Bio Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 58. Promega Corporation Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 59. Beijing TransGen Biotech Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 60. GeneScript Corporation Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 61. Yeastern Biotech Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 62. New England Biolabs Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 63. QIAGEN N.V. Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 64. OriGene Technologies Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 65. Lucigen Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 66. Zymo Research Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 68. Bioline Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 69. Delphi Genetics Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 70. IBA GmBH Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 71. Cell Applications Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 72. BioDynamics Laboratory Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 73. Scarab Genomics Revenue Growth Rate in Electrocompetent Cells Business (2020-2025)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Electroporated Competent Cells Market Research Report 2024

Global Electroporators Market Research Report 2024

Global E coli Competent Cells Market Research Report 2024

Global Electroporation Buffer Market Research Report 2025

Microbiology Electropermeabilization Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Electroporators Market Research Report 2024

Global Compact Electroporation System Market Research Report 2024

Global Electro Cell Fusion Generator Market Research Report 2024

Electroporation Instruments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Competent E coli Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Competent Yeast Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Transfection Technology Market Research Report 2024

Global Competent Cell Preparation Kit Market Research Report 2024

Global Live Cell Encapsulation Market Research Report 2024

Global Clone Competent Cell Market Research Report 2024

Global Electro Organic Synthesis Systems Market Research Report 2024

Global Replaceable Channel MembraneElectrode Electrolysis Cell Market Research Report 2024

Global Artificial Photosynthesis Market Research Report 2024

Global Prokaryotic Recombinant Protein Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions